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ABSTRACT 
Understanding mechanisms of gene regulation has broad therapeutic implications for human disease. Here we describe a novel 
method for generating human cell lines that serve as reporters of transcriptional activity. This method exploits the ability of 
recombinant adeno-associated virus to mediate the insertion of exogenous DNA sequences into specific genomic loci through 
homologous recombination. To overcome the severe size limitation of the rAAV for carrying exogenous DNA, an enhanced green 
fluorescent protein (EGFP)-Luciferase fusion gene was used as both a selectable marker and gene expression reporter. EGFP was 
used for selection of correctly targeted alleles by taking advantage of known regulatory conditions that activate transcription of 
specific genes. Using this method, we describe the generation of primary human fibroblasts that express EGFP-Luciferase under the 
control of the c-Myc oncogene. 
INTRODUCTION
Gene regulation is a complex process that involves the binding 
and recruitment of transcription factors to a wide variety of 
regulatory elements, including distal enhancers and proximal 
promoter sequences. Studies of gene regulation often employ 
artificial plasmid reporter systems that fuse regulatory regions to 
cDNAs   that   encode   reporter   genes   such   as   luciferase   or 
chloramphenicol   acetyl   transferase.   Although   it   is   well 
established that gene regulatory elements can function at long 
distance (>50kb) and may exist 5’, 3’ or be intergenic, most 
plasmid-based reporter systems require that only a relatively 
small DNA fragment(s) be used. Furthermore, the analysis of 
regulatory regions or presumptive regions is compromised in 
plasmid reporter systems, whether  in vivo  or  in vitro, by the 
artificial regulatory environment cultivated in this approach. 
While these limitations can be overcome by analysis of reporter 
genes   that   have   been   introduced   into   endogenous   loci   by 
plasmid-based   homologous   recombination   (1),   the   efficient 
generation of reporter cells by this method is hampered by a low 
efficiency of homologous recombination. For these reasons, we 
sought   to   develop   a   method   that   facilitates   the   efficient 
generation   of   reporter   cell   lines,   which   accurately   reflects 
endogenous gene regulation.
Recent   studies   have   shown   high   efficiency   gene   targeting 
through the use of recombinant Adeno-Associated Virus (rAAV)-
mediated homologous recombination in human somatic cells (2, 
3, 4). The efficiency of rAAV targeting surpasses traditional 
plasmid-based methods by several fold (4, 5), with up to 1% of 
unselected cells undergoing targeting (2, 6). Wild-type AAV is a 
single stranded DNA parvovirus with a 4.7 kb genome flanked 
by two inverted terminal repeats (ITR) (7). A number of rAAV-
mediated targeting strategies have been employed (2, 4, 8, 9, 10, 
11, 12, 13), and the general features of the rAAV targeting virus 
include   viral   ITRs   with   introduced   homologous   arms   that 
mediate recombination to specific genomic sites flanking a drug 
selection cassette. Importantly, the small packaging size of AAV 
(4.7 kb) severely restricts the amount of exogenous DNA that can 
be included in rAAV gene targeting vectors (7). For example 
when a typical drug selection cassette such as the ~1.7 kb PGK-
Neo-pA is used in the targeting vector, there remains space for 
inclusion of only 3 kb of targeting sequence, which is usually 
arranged as homology arms of at least 1kb. The high efficiency 
targeting of rAAV occurs despite the relatively small amounts of 
homologous   sequence   that   can   be   included.   However,   the 
inclusion of homologous arms together with a drug selection 
cassette restricts or precludes the addition of other sequences, 
such as reporter genes, larger than ~750 bps into the rAAV 
targeting vector. 
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To overcome the need to use a standard selectable marker gene, 
we have developed a new selection method for rAAV targeting. 
Our method relies on manipulation of known gene regulatory 
conditions   to   directly   select   for   the   introduction   of   a 
transcriptional reporter gene into a specific endogenous genetic 
locus. Here we describe the use of this method to develop 
primary human fibroblasts in which a promoter-less EGFP-
Luciferase (EGFP-Luc) fusion gene has been introduced into the 
c-Myc locus in frame with, and immediately downstream of the 
ATG translational start site.
These   cells   will   be   useful   for   studying   signal   transduction 
pathways and specific transcription factors that regulate c-Myc 
transcription.   Further,   these   and   other   reporter   cell   lines 
developed   using   techniques   described   here   may   provide   a 
robust platform for  conducting high-throughput screens for 
cDNAs,   siRNAs,   and   small   molecules   that   modulate 
endogenous gene expression. 
MATERIALS AND METHODS
HFF culture and cell cycle entry assays
Primary   human   foreskin   fibroblasts   (HFFs)   were 
generously provided at passage one from Carla Grandori 
(Fred Hutchinson Cancer Research Center). HFFs were 
routinely cultured in high glucose Dulbecco’s modified 
Eagle medium (DMEM) (Invitrogen) supplemented with 
10%   fetal   bovine   serum   (FBS)   (Hyclone),   100   U/mL 
penicillin, and 100 μg/mL streptomycin (Invitrogen) in 
incubators at 37°C and 5% CO2. For cell cycle entry assays, 
HFFs were first driven into quiescence by maintaining 
cells at confluence for 3 days in medium containing 10% 
FBS followed by 3 days of culture in DMEM containing 
0.1% FBS. Quiescent cells were stimulated to enter the cell 
cycle by the addition of medium containing 20% FBS. 
Construction and packaging rAAV gene targeting vectors
To facilitate production of rAAV targeting vectors that 
insert an EGFP-Luciferase reporter gene into target loci of 
interest we created the pEGFP-Luciferase cloning vector 
(pELCV).   A   promoter-less   EGFP-Luciferase-SV40   pA 
fusion gene was obtained from pEGFPLuc (Stratagene). To 
preserve a unique XbaI site in the final pELCV multiple 
cloning region, the pEGFPLuc XbaI site in the 3’ portion of 
the EGFP-Luciferase fusion gene was destroyed by XbaI 
digestion, Klenow fill-in, and blunt end ligation. The 2690 
bp   EGFP-Luciferase-pA  restriction   fragment   was   then 
removed from pEGFPLuc at NheI and MluI sites and 
made blunt by a Klenow fill-in reaction. This fragment 
was blunt end ligated into the SmaI site of pBluescript II 
SK+ (Stratagene). Addition of rAAV ITRs requires DNA 
fragments with 5’ and 3’ NotI ends. Therefore, a second 
NotI site was introduced into pELCV between the KpnI 
and XhoI recognition sequences using a KpnI NotI XhoI 
oligo   linker   to   complement   the   existing   NotI   in   the 
pBluescript II SK+ multiple cloning site.
Construction of the  c-Myc  EGFP-Luc knockin targeting 
vector was accomplished by PCR amplification of the c-
Myc  left and right homologous arms from the human 
genomic BAC RP11 237 F24 (Invitrogen) using primers 
containing   unique   exogenous   restriction   enzyme   sites 
(underlined). The 846 bp left homologous arm (LHA) was 
amplified   using   an   EcoRV   forward   primer 
(GGTCAGATATCGGAGGAACTGCGAGGAGC)   and   a 
PstI   reverse   primer 
(CTCGGTCCTGCAGCATCGTCGCGGGAGGCTGCTG) 
that   ends   with   the   c-Myc   ATG.   The   807   bp   right 
homologous arm (RHA) was amplified using a BamHI 
forward   primer 
(GGTCAGGATCCCCCCTCAACGTTAGCTTCACC) 
that starts with the first bp after the ATG and a XbaI 
reverse   primer 
(CTCGGTCTAGAGAAGGGATGGGAGGAAACGC). 
PCR product was restriction digested and sequentially 
ligated into pELCV. In-frame fusion of the  c-Myc  ATG 
with the start codon of the EGFP-Luc fusion gene was 
confirmed by sequencing. The AAV ITRs were introduced 
by ligation of the NotI targeting fragment into the pAAV-
hrGFP vector backbone (Stratagene). ITR flanked  c-Myc 
targeting   vector   integrity   was   confirmed   by   AhdI 
restriction mapping. 
rAAV vector stocks were prepared by cotransfection of the 
c-Myc  targeting   vector,   pAAV-RC   (Stratagene),   and 
pHelper (Stratagene) into 60% confluent AAV-293 cells 
(Stratagene) with lipofectamine (Invitrogen) as detailed in 
the   manufacturer’s   protocol.   rAAV   particles   were 
collected 3 days post-transfection by scraping cells from 
the 10 cm dish into 1 mL PBS pH 7.4 (Invitrogen) followed 
by 4 freeze/thaw cycles between a dry ice/ethanol bath 
and a 37°C water bath. Vector stocks were clarified by 
centrifugation and used fresh or stored at –80°C. The titer 
of the rAAV stock was ~1x10
6 viral particles/mL as verified 
by RT-PCR (25).
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Gene targeting in human fibroblasts
Homologous recombination is most efficiently facilitated 
by rAAV when target loci are in a euchromatic state due 
to active replication or transcription (7, 26). Therefore, to 
bias rAAV integration for homologous targeting instead of 
random integration events, rAAV was introduced to HFF 
cultures   in   log   phase   proliferation.   Primary   HFFs   at 
second passage were grown to 40% confluence (~2x10
6 
cells) in 10 cm plates. HFFs were then infected overnight 
using 333 μL c-Myc rAAV vector stock at a multiplicity of 
infection of ~0.5 particles/cell in 8 mL fresh medium. 
Infected   cells   were   given   fresh   media   24   hours   post 
infection and driven into quiescence by confluence arrest 
and   serum   deprivation  as   described   above.   To   select 
infected   cells   that   have   the   EGFP-Luc   gene   correctly 
inserted  immediately   downstream   of   the   c-Myc 
translation start site and therefore under the control of c-
Myc regulation, quiescent cells were stimulated with 20% 
serum for 6 hours. Stimulated cells were then trypsinized, 
strained through a 40 μM mesh to generate a single cell 
suspension at ~5x10
6  cells, and then sorted on a FACS 
Vantage with DiVa (Digital Vantage) upgrade (Becton 
Dickinson).   The   FACS   Vantage   was   programmed   to 
deliver single EGFP-Luc positive cells to individual wells 
of a 96 well tissue culture plate (Fig. 1B). Individual clones 
were expanded for genotype analysis.
Genotype analysis
Genomic DNA was isolated from individual EGFP-Luc 
positive clones. For PCR genotyping, triplex PCR was 
performed   using   one   primer   specific   for   the   LHA 
upstream of the EGFP-Luc insertion site (primer 1), one 
primer specific to the 3’ end of the EGFP-Luc fusion gene 
(primer 2), and one primer that recognizes sequence 3’ of 
the RHA that is outside the targeting construct (primer 3 - 
Fig. 2A). Primers 1 and 3 amplify a 1.5 kb product from 
the wildtype c-Myc allele. Primers 2 and 3 amplify a 1.1 kb 
product that indicates the EGFP-Luc fusion gene has been 
knocked into the c-Myc allele (Fig. 2B). For Southern blot 
analysis, 20 μg genomic DNA was digested with XbaI 
overnight, separated on a 0.8% 1xTAE agarose gel, and 
transferred to Hybond XL nylon membrane (Amersham). 
To identify correctly targeted  c-Myc  alleles membranes 
were hybridized with an α-
32P dCTP labeled c-Myc exon 3 
probe (Fig. 2A and C). To identify random integrations, an 
EGFP-specific probe was used (data not shown). Targeted 
clones were finally confirmed by sequencing across the 
regions   where   the   targeting   construct   juxtaposes   the 
genomic DNA as well as the EGFP-Luc insert regions 
within the targeting construct to insure the reporter gene 
was inserted inframe (Fig. 2D).
RT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen) 
and cDNA synthesized in a 20 μL reaction from 1 μg total 
RNA   using   Superscript   III   (Invitrogen)   and   random 
nonamer primers (Takara). 1 μL cDNA was used as RT-
PCR template to  detect  c-Myc  and  EGFP-Luc  mRNA 
expression. The  c-Myc  wildtype allele transcripts were 
detected   using   a   forward   primer, 
GCTCGCCCAAGTCCTGC, which anneals in exon 2, and 
a reverse primer, GCTGATGTGTGGAGACGTGG, which 
anneals in exon 3 (Fig. 4A). EGFP-Luc transcripts were 
detected from a primer pair annealing 3’ in the EGFP-Luc 
coding   region.   The   EGFP-Luc   forward   primer   is 
TATGGGCTCACTGAGACTACATCA   and   the   reverse 
primer is TCAGAGACTTCAGGCGGTCAA.
Western Blot
Protein was collected in 50mM Tris pH 7.4, 1% NP40, 
150mM NaCl, 1mM EDTA, 1mM Na3VO4, 1mM NaF, 1X 
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Fig.   1:  Direct   selection   of   targeted   EGFP-Luciferase   reporter 
gene   insertion   into   the  c-Myc  locus   using   known  c-Myc 
regulatory   conditions.  (A)  Subconfluent   primary   human   foreskin 
fibroblast cells are infected with rAAV targeting vectors when c-Myc is being 
actively transcribed or replicated in proliferative cells. Background reporter 
gene expression is silenced through density arrest and serum withdrawal. 
Reporter gene expression is induced by serum stimulation. Single EGFP-
Luciferase positive cells are selected using FACS. Cloned cells are expanded 
and   screened   for   gene   targeting   events   by  PCR,  Southern  blot,   and 
sequencing. (B) FACS histograms are shown for wildtype and c-Myc rAAV 
targeted cells following cell cycle entry. FL1-A (EGFP) was plotted against 
FL2-A (no fluorofor) to center the parent population and allow for selection 
of the dim EGFP-Luciferase positive cells. The P2 region of the plot 
indicates the gating used for selection of the EGFP-Luciferase positive 
portion of the parent population.87
Complete Protease Inhibitor (Roche). 10 μg of protein was 
separated by electrophoresis in 4-12% Bis-Tris NuPage 
gels   (Invitrogen)   and   transferred   onto   nitrocellulose 
membrane (Nitrocellulose Transfer Membrane - Bio-Rad). 
Membranes were probed with 1:200 anti-c-Myc (9E10) 
(Santa Cruz), 1:2000 anti-GFP (JL-8) (Clontech), and 1:500 
anti-Max (C-17) (Santa Cruz) antibodies.
Luciferase Assays
Cells were collected from 10 cm dishes into 500 μL Tropix 
lysis solution supplemented with fresh 0.5 mM DTT. 10 μL 
of cellular lysate was added to 25 μL Dual Light Buffer A 
in a 96 well plate. Samples were assayed for Luciferase 
activity on a Tropix TR717 Microplate Luminometer (PE 
Applied Biosystems). Samples were run in triplicate and 
the average data are reported +/- SEM.
RESULTS AND DISCUSSION
Transcription of the c-Myc gene is tightly regulated and 
events   such   as   viral   transduction,   viral   integration, 
chromosomal translocations and gene amplification that 
deregulate   c-Myc  transcription   activate   its   well-
characterized oncogenic potential (14). In addition, c-Myc 
mRNA and protein levels are deregulated or elevated in 
many tumors that show no physical disruption at the gene 
level. In the latter cases, deregulated c-Myc expression is 
thought to be due to oncogenic activation of mitogenic 
signal transduction pathways that regulate  c-Myc  gene 
expression (15, 16, 17). Indeed the c-Myc gene has been 
found to be induced by a wide variety of mitogenic 
proteins and suppressed by anti-mitogenic proteins (14). 
Although c-Myc transcription is regulated at a variety of 
levels (18), it remains unclear how the various mitogenic 
and   anti-mitogenic   signals  converge   on   the  c-Myc 
promoter to control gene expression (19). Therefore, to 
facilitate mechanistic studies of c-Myc gene regulation in 
human cells we devised a strategy, depicted in Fig. 1A, to 
generate primary human foreskin fibroblasts (HFF) that 
serve as reporters of c-Myc transcription. In this strategy, 
we take advantage of the well-documented induction of c-
Myc transcription that occurs upon serum stimulation of 
quiescent cells (20, 21, 22) to select, by FACS sorting, for 
rAAV-mediated knockin of an EGFP-Luc reporter gene 
into   the  c-Myc  locus.  As   described   in   Materials   and 
Methods, the rAAV vector was designed to insert the 2690 
bp promoter-less EGFP-Luc fusion gene into exon 2 of the 
c-Myc locus in frame with the major c-Myc translational 
start codon. Insertion of the reporter gene is predicted to 
produce a chimeric transcript comprised of the c-Myc 5’ 
untranslated   region   fused   to   EGFP-Luc.   A 
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Fig.   2:Genotype   analysis   of   EGFP-Luciferase   positive   clonal 
populations.  (A)  Diagram of the  c-Myc  rAAV targeting and genotype 
strategies. The targeting region of the endogenous c-Myc locus is shown. 
The left and right homologous arms (LHA & RHA), and viral inverted 
terminal repeat portions of the rAAV vectors facilitate insertion of the EGFP-
Luciferase fusion gene directly between the first and second codon of the c-
Myc gene. K, KpnI. X, XbaI. C, ClaI. S, SspI. (B) Triple primer PCR genotyping 
was performed using primers 1-3 shown in (A). (C) Southern blot analysis 
using the c-Myc exon 3 probe shown in (A). (D) Sequence data showing the 
regions spanning the  c-Myc  rAAV insertion sites and the internal EGFP-
Luciferase insertion regions.
Fig. 3: MR1 and MR2 response to cell cycle entry. MR1 (A) and 
MR2 (B) clonal populations were subjected to cell cycle entry conditions 
and then evaluated for EGFP-Luc reporter gene expression. The 
unstimulated background control populations are shown in the top panels. 
Serum stimulated populations are shown in the bottom panels where the 
EGFP-Luciferase expressing cells are located in the P2 gated region. 88
polyadenylation signal on the EFGP-Luc cDNA prevents 
read-through transcription of downstream sequences and 
therefore its insertion inactivates the targeted c-Myc allele. 
However, the reporter gene knockin is predicted to result 
in   minimal   disruption   of   the   native   cis   regulatory 
sequences that govern  c-Myc  transcription so that the 
reporter   gene   will   provide   an   accurate   readout   of 
endogenous c-Myc activity. 
Generating  c-Myc  gene reporter human fibroblast cell 
lines
Primary HFFs at passage 2 were infected with the c-Myc 
rAAV targeting vector for 24 hours. The infected cells 
were then driven into quiescence by combined confluence 
arrest and serum deprivation (Fig. 1A). These cells were 
stimulated to reenter the cell cycle by the addition of 20% 
serum for 6 hours and subjected to fluorescence activated 
cell   sorting   (FACS)   for   cells   that   expressed   EGFP. 
Although, c-Myc is maximally induced between 2 and 4 
hours following serum stimulation (Fig. 4), the 6 hour 
time point was chosen for sorting to ensure that cells had 
entered the cell cycle and because EFGP-Luc has a much 
longer half life (~15 hrs, data not shown) than the short, 
20-30 minute half life of c-Myc (21, 23, 24). Of 5x10
5 cells 
sorted, 48 cells (0.01% of the parent population) showed 
expression of EGFP-Luc (Fig. 1B). EGFP-positive  cells 
were automatically collected and sorted into individual 
wells of a 96 well dish by the flow cytometry instrument. 
Of the 48 cells plated, 24 grew out to formed viable 
colonies. The 24 clonal populations were expanded, DNA 
extracted and had PCR and Southern blot genotyping 
performed. Five clones (21%) were found to carry a single 
targeted c-Myc allele (Fig. 2B and C). DNA from these five 
clones was subjected to sequence analysis to confirm that 
the EGFP-Luc gene was inserted correctly. All five showed 
correct in-frame insertion of the reporter beginning after 
the ATG of the major c-Myc translation start site. Sequence 
at the insertion junctions for a representative clone is 
shown   in   Fig.   2D.   These   results   are   consistent   with 
previous results showing that AAV vectors can precisely 
insert DNA at specific genomic loci (2).
rAAV-mediated gene targeting vectors can also integrate 
at random locations (2). To determine whether random 
integration of the EGFP-Luc gene occurred in our selected 
clones, Southern blots were performed using a probe 
specific to the EGFP-Luc gene (not shown). This analysis 
showed three of the 24 clones with random integration 
events and that Clone 9 had one random integration event 
(not shown) and one correctly targeted c-Myc allele (Fig. 
2B and C). The other 4 positive clones showed only a 
single correctly targeted c-Myc allele (Fig. 2B and C) and 
no random integration events (not shown). 
We conclude from these results that even though the rate 
of return of EGFP-Luc positive cells following infection of 
HFFs with the rAAV- c-Myc targeting vector is low, FACS 
provides a powerful selection method that can rapidly 
yield productive cell lines from very rare, but precise 
targeting events. It is of note that we have found that use 
of a high titer virus at a high multiplicity significantly 
improves the percent yield of EGFP-Luc positive cells 
compared   to   the   low   titer   stocks   used   in   these 
experiments. 
Comparison of endogenous  c-Myc  expression to  c-Myc 
reporter activity
Clones 7 and 8 (designated c-Myc reporter 1 [MR1] and 2 
[MR2]) were chosen for further characterization because 
these populations showed correct targeting and did not 
contain any random rAAV integration events. We first 
performed a cell cycle entry experiment using the same 
conditions used in the original selection scheme (Fig. 1A). 
FAC sorting 6 hours following serum stimulation yielded 
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Fig. 4: Comparison of c-Myc and EGFP-Luciferase reporter gene 
expression and activity kinetics in response to cell cycle entry. 
The MR1 cells were tracked through CCE for their ability to induced c-Myc 
and EGFP-Luciferase transcripts by RT-PCR (A) and protein by Western blot 
(B). Max protein expression is used as a loading control. (C) Luciferase 
activity of the MR1 population over CCE. Data shown is the average of 
triplicate samples +/- SEM. (D) FACS Calibur data is shown where the 
EGFP-Luciferase positive percent of the parent population was determined 
using BD CellQuest Pro v. 5.2. Time course changes of the percent EGFP-
Luciferase expressing populations were compared under the same gates. 89
20.2% of the MR1 population (Fig. 3A) and 7.29% of the 
MR2 population (Fig. 3B) positive for EGFP-Luc. This is 
compared   to  0.74%   and   0.03%  of  EGFP-positive   cells 
observed in the unstimulated MR1 and MR2 populations 
respectively (Fig. 3). Thus, MR1 cells show a 27-fold 
induction and MR2 cells show a 243-fold induction of the 
EGFP reporter 6 hours after serum stimulation. Although 
there is a strong induction of EGFP, it was clear that not all 
cells induce the reporter by 6 hours. We therefore further 
examined   the   induction  kinetics   of  the   reporter   gene 
compared to c-Myc expression during cell cycle entry of 
MR1   cells   to   determine   whether   the   inserted   EGFP 
reporter genes recapitulated expression characteristics of 
the c-Myc gene. 
Induction of  c-Myc  transcription and protein following 
serum stimulation of quiescent fibroblasts peaks between 
2-4   hours,   and   subsequently   declines   to   low,   but 
measurable levels by 24 hours and throughout the cell 
cycle (20, 21, 22, 23, 24). Cell cycle entry experiments were 
conducted using MR1 cells collected at 0, 2, 4, 8, 16, and 24 
hours post stimulation. c-Myc and EGFP-Luc transcripts 
were induced upon serum stimulation and subsequently 
declined with near-identical kinetics (Fig. 4A). EGFP-Luc 
was also strongly induced, but its induction to measurable 
levels appeared to be delayed compared to c-Myc protein 
(Fig. 4B). It is not clear why EGFP is not detected by 2 
hour after serum stimulation, as c-Myc is, but this may 
have to do with the relative strength of the antibodies, or 
due to a slower rate of translation of the EGFP-Luc fusion 
mRNA compared to  c-Myc  mRNA. EGFP-Luc protein 
levels also differed from endogenous c-Myc protein levels 
in that whereas c-Myc levels declined after 4 hours, EGFP-
Luc continued to accumulate throughout the 24 hour 
period monitored (Fig. 4B). The progressive accumulation 
of EGFP-Luc is a reflection of the much longer half-life of 
EGFP-Luc fusion protein (~15hrs) compared to the 20-30 
minute half-life of c-Myc. 
The accumulation of EGFP-Luc protein following serum 
stimulation was also reflected in a progressive increase 
over the 24 hour period in Luciferase activity (Fig. 4C) and 
in an robust increase in the percentage of EGFP-positive 
cells (Fig. 4D). Notably, the fold induction of Luciferase 
activity (4.5 fold) was lower that that of EGFP (10 fold) 
(Fig. 4C and D). The reason for this discrepancy is not 
clear,   but   may   reflect   underlying   differences   in   the 
detection instruments. Importantly, the low background of 
EFGP-Luciferase   in   quiescent   cells   together   with   the 
progressive accumulation of EGFP-Luc signal, appear to 
provide conditions that allow an amplification of events, 
like serum stimulation, that trigger c-Myc transcription.
Summary
We demonstrate here a method for rapidly producing 
human   gene   reporter   cells   by   rAAV-mediated   gene 
insertion, and characterize a  c-Myc  gene reporter cell 
strain that we developed using this method. Our method 
for reporter insertion is applicable to any gene whose 
expression can be induced from a low basal level. For 
example, a number of genes such as cyclins and cell cycle 
inhibitor/checkpoint genes have well-defined conditions 
in which their expression can be induced from a low level. 
Reporter cells for these genes and in particular genes that 
are involved in cancer and other diseases offer a possible 
platform for the identification of proteins and molecules 
with potential therapeutic value. 
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PROTOCOL
Generating reporter knockin cell line
1. Determine gene to be targeted based on its ability to be induced under defined cell culture conditions (i.e. cell cycle entry).
2. Clone target gene-specific arms into pELCV vector. The 5’ arm should include the translation start codon of the target gene 
and cloning should be engineered to generate in-frame fusion with the GFP-Luciferase reporter in pELCV. The goal being 
to maintain endogenous gene regulatory sequences and context while introducing the reporter gene.
3. Sequence vector to ensure junction sequences are correct.
4. Generate infectious recombinant AAV. 
5. Infect cells under logarithmic growth to favor sequence-specific recombination. 
Activate gene transcription of GFP-Luc reporter targeted gene (e.g. cell cycle entry for c-Myc).
6. Used FAC sorting to select cells that show induction of GFP that mimics expression of the targeted gene.
7. Directly plate GFP-positive single cells in 96 well plate or pool positive cells for expansion.
8. Expanded GFP-positive clones or pooled populations can either be genotyped at this point or run through an “enrichment” 
step. For enrichment, cells are put through a second round of selection using the gene-inducing conditions followed by 
FAC sorting of GFP-position cells. Enriched cell populations are expanded and genotyped.
9. Correctly targeted cells are used in assays in which expression of the targeted gene, as determined by either GFP (e.g. using 
FACS) or luciferase activity is the readout. Either approach could be used in a high-throughput screening format.
Fernandez et al. – Development of human gene reporter cell lines using rAAV mediated homologous recombination
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